Latest / Decera Clinical Education Oncology Podcast
Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers
In this episode, Prof Isabelle Ray Coquard, MD, PhD, and Ignace Vergote, MD, PhD, share their thoughts on key studies of interested presented at the 2022 ESGO annual meeting in Berlin, Germany, including:
• Phase III CALLA trial of durvalumab combined with and following chemoradiotherapy in locally advanced cervical cancer
• Geneva HRD test: validation of samples from PAOLA-1 dataset using Geneva laboratory–developed test
• Validation of NOGGO-GIS HRD assay using samples from the PAOLA-1 trial
• Survival results from phase III ARIEL3: maintenance rucaparib vs placebo following response to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.